The INTRA office would like to ensure that parents and guardians fully understand the programme. We hope you can appreciate that our relationship is with the student and we cannot communicate with ...

The nine-page memo from the department’s Office for Civil Rights said NIL money that goes to athletes should be treated the same as athletic financial aid — i.e., scholarships. It’s a position that, ...

the memo said. The organization is not alone in its predictions for the coming weeks, with the National Immigration Forum also stating Tuesday that it expects a busy first 100 days in office for ...

Senate Democrats are circulating a memo claiming that President-elect Donald Trump’s nominee for Treasury secretary, Scott Bessent, improperly claimed nearly $2 million in tax losses and owes ...

Meta Platforms is cutting 5% of its workforce, according to an internal memo that circulated on Tuesday, first reported by Bloomberg. The company declined to comment to several outlets but ...

CEO Mark Zuckerberg informed employees about the decision to “move out low performers faster” in a memo posted on the company’s internal Workplace forum on Tuesday. Zuckerberg told ...

DOGE Caucus leaders had previously put an emphasis on "low-hanging fruit" to start their mission with, like unused federal office space held by agencies with remote work policies. The memo puts ...

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...

本文来自：华尔街见闻，作者：张雅琦，原文标题：《近两年来最大生物技术并购！强生百亿收购Intra-Cellular，后者盘前飙升近38%》 强生收购Intra-Cellular，将目光瞄准中枢神经系统疾病市场。 1月13日，强生公司以146亿美元收购Intra-Cellular Therapies，以增强其在神经 ...

Johnson & Johnson will acquire Intra-Cellular for $132 per share in cash, a 39 percent premium over Intra-Cellular's Friday closing price of $94.87. Following the announcement, shares of both ...

8, 2024. (AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of ...

Johnson & Johnson will acquire Intra-Cellular Therapies for $132 per share in a deal that values the company at $14.6 billion. The acquisition includes FDA-approved CAPLYTA for schizophrenia and ...